Facial basal cell carcinoma

BMJ (Online)

Volumn 345, Issue 7871, 2012, Pages

  Baxter, Julia M ^a   Patel, Anand N ^a   Varma, Sandeep ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; IMIQUIMOD;

BASAL CELL CARCINOMA; BLISTER; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CARBON DIOXIDE LASER; CAUTERIZATION; CHEMOSURGERY; CLINICAL EXAMINATION; CLINICAL FEATURE; CRYOTHERAPY; CURETTAGE; EPILUMINESCENCE MICROSCOPY; ERBIUM YAG LASER; ESTHETICS; FACE CANCER; FLU LIKE SYNDROME; HISTOPATHOLOGY; HUMAN; LASER SURGERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN BIOPSY; SKIN REDNESS; SKIN SURGERY; SKIN ULCER; TELANGIECTASIA; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; FACE TUMOR; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; PROGNOSIS; SKIN TUMOR;

CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; CRYOTHERAPY; FACIAL NEOPLASMS; HUMANS; MOHS SURGERY; PHOTOCHEMOTHERAPY; PROGNOSIS; SKIN NEOPLASMS;

EID: 84865420986     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e5342     Document Type: Review

References (34)

1. Camp WL, Turnham JW, Athar M, Elments CA. New agents for prevention of ultraviolet-induced nonmelanoma skin cancer. Semin Cutan Med Surg 2011;30:6-13.
2. Madan V, Lear JT, Szeimies R-M. Non-melanoma skin cancer. Lancet 2010;375:673-85.
3. Nakayama M, Tabuchi K, Nakamura Y, Hara A. Basal cell carcinoma of the head and neck. J Skin Cancer 2011;2011:496910.
4. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005;353:2262-9. (Pubitemid 41697289)
5. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003;149:1200-6. (Pubitemid 38058096)
6. Jung GW, Metelitsa AI, Dover DC, Salopek TG. Trends in incidence of nonmelanoma skin cancers in Alberta, Canada, 1988-2007. Br J Dermatol 2010;163:146-54.
7. McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol 1997;133:593-6. (Pubitemid 27214968)
8. Lear JT, Harvey I, de Berker D, Strange RC, Fryer AA. Basal cell carcinoma. J R Soc Med 1998;91:585-8. (Pubitemid 28561107)
9. Mantese SAO, Berbert ALCW, Gomides MDA, Rocha A. Basal cell carcinoma - analysis of 300 cases observed in Uberlândia-MG, Brazil. An Bras Dermatol 2006;81:136-42. (Pubitemid 46768102)
10. De Vries E, Louwman M, Bastiaens M, de Gruijl F, Coebergh JW. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol 2004;123:634-8. (Pubitemid 39281602)
11. Flohil SC, de Vries E, Neumann HAM, Coebergh JW, Nijsten T. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011;91:24-30.
12. Custódio G, Locks LH, Coan MF, Gonçalves CO, Trevisol DJ, Trevisol FS. Epidemiology of basal cell carcinomas in Tubarão, Santa Catarina (SC), Brazil between 1999 and 2008. An Bras Dermatol 2010;85:819-26.
13. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999;135:781-6. (Pubitemid 29330800)
14. Brewster DH, Bhatti LA, Inglis JHC, Nairn ER, Doherty VR. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol 2007;156:1295-300. (Pubitemid 47029828)
15. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000;143:1224-9. (Pubitemid 32052759)
16. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 2006;184:6-10. (Pubitemid 43149790)
17. Alam M, Goldberg LH, Silapunt S, Gardner ES, Strom SS, Rademaker AW, et al. Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 2011;64:839-48.
18. Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol 1993;38:169-92. (Pubitemid 23297230)
19. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008;159:35-48. (Pubitemid 351874512)
20. Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007;156(3 suppl):1-7. (Pubitemid 46646534)
21. Hoey SEH, Devereux CEJ, Murray L, Catney D, Gavin A, Kumar S, et al. Skin cancer trends in Northern Ireland and consequences for provision of dermatology services. Br J Dermatol 2007;156:1301-7. (Pubitemid 47029856)
22. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998;78:144-8. (Pubitemid 28443167)
23. Donaldson MR, Coldiron BM. No end in sight: the skin cancer epidemic continues. Semin Cutan Med Surg 2011;30:3-5.
24. Chinem VP, Miot HA. Epidemiology of basal cell carcinoma. An Bras Dermatol 2011;86:292-305.
25. Lear JT, Smith AG. Basal cell carcinoma. Postgrad Med J 1997;73:538-42. (Pubitemid 27448250)
26. Cancer Research UK. Skin cancer risks and causes. 2011. http://cancerhelp.cancerresearchuk.org/type/skin-cancer/about/ skin-cancer-risks-and-causes.
27. Diffey BL, Langtry JAA. Skin cancer incidence and the ageing population. Br J Dermatol 2005;153:679-80. (Pubitemid 41248242)
28. Chuang TY, Popescu A, Su WP, Chute CG. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990;22:413-7. (Pubitemid 20212392)
29. Richmond-Sinclair NM, Pandeya N, Ware RS, Neale RE, Williams GM, van der Pols JC, et al. Incidence of basal cell carcinoma multiplicity and detailed anatomic distribution: longitudinal study of an Australian population. J Invest Dermatol 2009;129:323-8.
30. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002;138:1043-51. (Pubitemid 34875608)
31. Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2007;157:47-51. (Pubitemid 350179630)
32. Kopke L, Schmidt S. Basal cell carcinoma. An Bras Dermatol 2002;77:249-85. (Pubitemid 35339663)
33. Vico P, Fourez T, Nemec E, Deraemaecker R. Aggressive basal cell carcinoma of head and neck areas. Eur J Surg Oncol 1995;21:490-7.
34. Takenouchi T, Nomoto S, Ito M. Factors influencing the linear depth of invasion of primary basal cell carcinoma. Dermatol Surg 2001;27:393-6. (Pubitemid 32290869)